Thermo Fisher
The $9.4 Billion Bet on Code: Why Thermo Fisher’s Mega-Deal for a Software Company Is Reshaping Medicine
Thermo Fisher’s $9.4B acquisition of Clario isn’t just a deal; it’s a bet on the future of medicine, powered by software, AI, and cloud technology.